Atto Billio

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial

Andrea Gallamini, Francesco Zaja, Caterina Patti et al. · Blood · 2007 · 308 citations · Full text

Medicine, Oncology, Chemotherapy +9

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani et al. · Journal of Clinical Oncology · 2018 · 200 citations

Medicine, Oncology, Pharmacology +15

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines

Valeria Santini, P Alessandrino, Emanuele Angelucci et al. · Leukemia Research · 2010 · 115 citations

Medicine, Hematology, Internal Medicine +16

Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP.

E Bobbio-Pallavicini, L Gugliotta, Riccardo Centurioni et al. · PubMed · 1997 · 113 citations

Medicine, Pharmacology, Pharmacotherapy +12